RIVM to research safe design for new nanoparticles RIVM will be working alongside a consortium of 23 international partners on a safe design for ‘new’ nanoparticles.
The National Immunisation Programme in the Netherlands: Developments in 2013 Annually RIVM provides an overview of key events and developments in the National Immunisation Programme (NIP).
Nanotechnology in the fight against cancer Nanotechnology offers improved options for the diagnosis and treatment of cancer.
Cervical cancer screening in the Netherlands January 19 - 25 European Cervical Cancer Prevention Week.
Further research into hazards posed by e-cigarettes Safety of nicotine-containing electronic cigarettes (e-cigarettes) cannot be confirmed because of the limited amount of published research in this area.
Fewer municipalities with low vaccination coverage In the Netherlands, there are 80 municipalities with a low vaccination coverage for one or more vaccinations. This is a decrease compared to last year when there were still 90 municipalities.
Regulation of nanomaterials needs more than definition alone In a new publication, RIVM indicates scientific challenges in the use of the EU definition for nanomaterial in legislation.
ICP M&M meetings in 2013 The 23rd CCE Workshop and 29th Task Force Meeting of the ICP M&M will be held 8-11 April 2013 in Copenhagen, Denmark.
Call for data on "no net loss of biodiversity" The CCE is pleased to publicate an announcement and a detailed substantiation and technical description of the call for data on “no net loss of biodiversity” which has been adopted at the 31st meet
EC-definition of nanomaterial provides proper basis In recent years, an increasing number of applications and products containing or using nanomaterials have become available.